Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome.

Kosumi K, Hamada T, Koh H, Borowsky J, Bullman S, Twombly TS, Nevo D, Masugi Y, Liu L, da Silva A, Chen Y, Du C, Gu M, Li C, Li W, Liu H, Shi Y, Mima K, Song M, Nosho K, Nowak JA, Nishihara R, Baba H, Zhang X, Wu K, Wang M, Huttenhower C, Garrett WS, Meyerson ML, Lennerz JK, Giannakis M, Chan AT, Meyerhardt JA, Fuchs CS, Ogino S.

Am J Pathol. 2018 Dec;188(12):2839-2852. doi: 10.1016/j.ajpath.2018.08.015. Epub 2018 Sep 20.

PMID:
30243655
2.

Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status.

Hamada T, Zhang X, Mima K, Bullman S, Sukawa Y, Nowak JA, Kosumi K, Masugi Y, Twombly TS, Cao Y, Song M, Liu L, da Silva A, Shi Y, Gu M, Li W, Koh H, Nosho K, Inamura K, Keum N, Wu K, Meyerhardt JA, Kostic AD, Huttenhower C, Garrett WS, Meyerson M, Giovannucci EL, Chan AT, Fuchs CS, Nishihara R, Giannakis M, Ogino S.

Cancer Immunol Res. 2018 Nov;6(11):1327-1336. doi: 10.1158/2326-6066.CIR-18-0174. Epub 2018 Sep 18.

PMID:
30228205
3.

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.

Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, Czerniak BA, Reuter VE, Su X, de Sa Carvalho B, Chagas VS, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, Mills GB, McConkey DJ; TCGA Research Network, Weinstein JN, Kwiatkowski DJ, Lerner SP.

Cell. 2018 Aug 9;174(4):1033. doi: 10.1016/j.cell.2018.07.036. No abstract available.

PMID:
30096301
4.

GATK PathSeq: a customizable computational tool for the discovery and identification of microbial sequences in libraries from eukaryotic hosts.

Walker MA, Pedamallu CS, Ojesina AI, Bullman S, Sharpe T, Whelan CW, Meyerson M.

Bioinformatics. 2018 Dec 15;34(24):4287-4289. doi: 10.1093/bioinformatics/bty501.

PMID:
29982281
5.

Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum.

Liu L, Tabung FK, Zhang X, Nowak JA, Qian ZR, Hamada T, Nevo D, Bullman S, Mima K, Kosumi K, da Silva A, Song M, Cao Y, Twombly TS, Shi Y, Liu H, Gu M, Koh H, Li W, Du C, Chen Y, Li C, Li W, Mehta RS, Wu K, Wang M, Kostic AD, Giannakis M, Garrett WS, Hutthenhower C, Chan AT, Fuchs CS, Nishihara R, Ogino S, Giovannucci EL.

Clin Gastroenterol Hepatol. 2018 Oct;16(10):1622-1631.e3. doi: 10.1016/j.cgh.2018.04.030. Epub 2018 Apr 24.

PMID:
29702299
6.

Mechanistic Insights into Transmissible Cancers of Mammals.

Bullman S, Zou T, Meyerson M.

Cancer Cell. 2018 Apr 9;33(4):543-544. doi: 10.1016/j.ccell.2018.03.019.

PMID:
29634941
7.

The Immune Landscape of Cancer.

Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CE; Cancer Genome Atlas Research Network, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich L.

Immunity. 2018 Apr 17;48(4):812-830.e14. doi: 10.1016/j.immuni.2018.03.023. Epub 2018 Apr 5.

8.

Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.

Liu Y, Sethi NS, Hinoue T, Schneider BG, Cherniack AD, Sanchez-Vega F, Seoane JA, Farshidfar F, Bowlby R, Islam M, Kim J, Chatila W, Akbani R, Kanchi RS, Rabkin CS, Willis JE, Wang KK, McCall SJ, Mishra L, Ojesina AI, Bullman S, Pedamallu CS, Lazar AJ, Sakai R; Cancer Genome Atlas Research Network, Thorsson V, Bass AJ, Laird PW.

Cancer Cell. 2018 Apr 9;33(4):721-735.e8. doi: 10.1016/j.ccell.2018.03.010. Epub 2018 Apr 2.

9.

Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.

Campbell JD, Yau C, Bowlby R, Liu Y, Brennan K, Fan H, Taylor AM, Wang C, Walter V, Akbani R, Byers LA, Creighton CJ, Coarfa C, Shih J, Cherniack AD, Gevaert O, Prunello M, Shen H, Anur P, Chen J, Cheng H, Hayes DN, Bullman S, Pedamallu CS, Ojesina AI, Sadeghi S, Mungall KL, Robertson AG, Benz C, Schultz A, Kanchi RS, Gay CM, Hegde A, Diao L, Wang J, Ma W, Sumazin P, Chiu HS, Chen TW, Gunaratne P, Donehower L, Rader JS, Zuna R, Al-Ahmadie H, Lazar AJ, Flores ER, Tsai KY, Zhou JH, Rustgi AK, Drill E, Shen R, Wong CK; Cancer Genome Atlas Research Network, Stuart JM, Laird PW, Hoadley KA, Weinstein JN, Peto M, Pickering CR, Chen Z, Van Waes C.

Cell Rep. 2018 Apr 3;23(1):194-212.e6. doi: 10.1016/j.celrep.2018.03.063.

10.

Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer.

Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang X, Cai D, Neuberg D, Huang K, Guevara F, Nelson T, Chipashvili O, Hagan T, Walker M, Ramachandran A, Diosdado B, Serna G, Mulet N, Landolfi S, Ramon Y Cajal S, Fasani R, Aguirre AJ, Ng K, √Člez E, Ogino S, Tabernero J, Fuchs CS, Hahn WC, Nuciforo P, Meyerson M.

Science. 2017 Dec 15;358(6369):1443-1448. doi: 10.1126/science.aal5240. Epub 2017 Nov 23.

PMID:
29170280
11.

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.

Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, Czerniak BA, Reuter VE, Su X, de Sa Carvalho B, Chagas VS, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, Mills GB, McConkey DJ; TCGA Research Network, Weinstein JN, Kwiatkowski DJ, Lerner SP.

Cell. 2017 Oct 19;171(3):540-556.e25. doi: 10.1016/j.cell.2017.09.007. Epub 2017 Oct 5. Erratum in: Cell. 2018 Aug 9;174(4):1033.

12.

Metagenomic Characterization of Microbial Communities In Situ Within the Deeper Layers of the Ileum in Crohn's Disease.

Pedamallu CS, Bhatt AS, Bullman S, Fowler S, Freeman SS, Durand J, Jung J, Duke F, Manzo V, Cai D, Ananthakrishnan A, Ojesina AI, Ramachandran A, Gevers D, Xavier RJ, Bhan AK, Meyerson M, Yajnik V.

Cell Mol Gastroenterol Hepatol. 2016 May 26;2(5):563-566.e5. doi: 10.1016/j.jcmgh.2016.05.011. eCollection 2016 Sep.

13.

Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue.

Mehta RS, Nishihara R, Cao Y, Song M, Mima K, Qian ZR, Nowak JA, Kosumi K, Hamada T, Masugi Y, Bullman S, Drew DA, Kostic AD, Fung TT, Garrett WS, Huttenhower C, Wu K, Meyerhardt JA, Zhang X, Willett WC, Giovannucci EL, Fuchs CS, Chan AT, Ogino S.

JAMA Oncol. 2017 Jul 1;3(7):921-927. doi: 10.1001/jamaoncol.2016.6374.

14.

Emerging Concepts and Technologies for the Discovery of Microorganisms Involved in Human Disease.

Bullman S, Meyerson M, Kostic AD.

Annu Rev Pathol. 2017 Jan 24;12:217-244. doi: 10.1146/annurev-pathol-012615-044305. Epub 2016 Dec 5. Review.

PMID:
27959634
15.

Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location.

Mima K, Cao Y, Chan AT, Qian ZR, Nowak JA, Masugi Y, Shi Y, Song M, da Silva A, Gu M, Li W, Hamada T, Kosumi K, Hanyuda A, Liu L, Kostic AD, Giannakis M, Bullman S, Brennan CA, Milner DA, Baba H, Garraway LA, Meyerhardt JA, Garrett WS, Huttenhower C, Meyerson M, Giovannucci EL, Fuchs CS, Nishihara R, Ogino S.

Clin Transl Gastroenterol. 2016 Nov 3;7(11):e200. doi: 10.1038/ctg.2016.53.

16.

Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.

Mima K, Nishihara R, Qian ZR, Cao Y, Sukawa Y, Nowak JA, Yang J, Dou R, Masugi Y, Song M, Kostic AD, Giannakis M, Bullman S, Milner DA, Baba H, Giovannucci EL, Garraway LA, Freeman GJ, Dranoff G, Garrett WS, Huttenhower C, Meyerson M, Meyerhardt JA, Chan AT, Fuchs CS, Ogino S.

Gut. 2016 Dec;65(12):1973-1980. doi: 10.1136/gutjnl-2015-310101. Epub 2015 Aug 26.

17.

Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.

Mima K, Sukawa Y, Nishihara R, Qian ZR, Yamauchi M, Inamura K, Kim SA, Masuda A, Nowak JA, Nosho K, Kostic AD, Giannakis M, Watanabe H, Bullman S, Milner DA, Harris CC, Giovannucci E, Garraway LA, Freeman GJ, Dranoff G, Chan AT, Garrett WS, Huttenhower C, Fuchs CS, Ogino S.

JAMA Oncol. 2015 Aug;1(5):653-61. doi: 10.1001/jamaoncol.2015.1377.

18.

Draft Genome Sequence of Campylobacter corcagiensis Strain CIT045T, a Representative of a Novel Campylobacter Species Isolated from Lion-Tailed Macaques (Macaca silenus).

Koziel M, Lucid A, Bullman S, Corcoran GD, Lucey B, Sleator RD.

Genome Announc. 2014 Apr 17;2(2). pii: e00248-14. doi: 10.1128/genomeA.00248-14.

19.

Draft Genome Sequence of Campylobacter ureolyticus Strain CIT007, the First Whole-Genome Sequence of a Clinical Isolate.

Lucid A, Bullman S, Koziel M, Corcoran GD, Cotter PD, Sleator RD, Lucey B.

Genome Announc. 2014 Apr 10;2(2). pii: e00262-14. doi: 10.1128/genomeA.00262-14.

20.
21.

Identification and genetic characterization of a novel picornavirus from chickens.

Bullman S, Kearney K, O'Mahony M, Kelly L, Whyte P, Fanning S, Morgan JG.

J Gen Virol. 2014 May;95(Pt 5):1094-103. doi: 10.1099/vir.0.061085-0. Epub 2014 Feb 4.

PMID:
24496829
22.

Genomic investigation into strain heterogeneity and pathogenic potential of the emerging gastrointestinal pathogen Campylobacter ureolyticus.

Bullman S, Lucid A, Corcoran D, Sleator RD, Lucey B.

PLoS One. 2013 Aug 30;8(8):e71515. doi: 10.1371/journal.pone.0071515. eCollection 2013.

23.

Molecular-based detection of the gastrointestinal pathogen Campylobacter ureolyticus in unpasteurized milk samples from two cattle farms in Ireland.

Koziel M, Lucey B, Bullman S, Corcoran GD, Sleator RD.

Gut Pathog. 2012 Nov 14;4(1):14. doi: 10.1186/1757-4749-4-14.

24.

Epsilonproteobacteria in humans, New Zealand.

Bullman S, Corcoran D, O'Leary J, Byrne D, Lucey B, Sleator RD.

Emerg Infect Dis. 2012 Oct;18(10):1709-10; author reply 1710-1. doi: 10.3201/eid1810.120369. No abstract available.

25.

Molecular diagnostics: the changing culture of medical microbiology.

Bullman S, Lucey B, Sleator RD.

Bioeng Bugs. 2012 Jan 1;3(1):1-7. doi: 10.4161/bbug.3.1.19011. Epub 2012 Jan 1.

PMID:
22179143
26.

Emerging dynamics of human campylobacteriosis in Southern Ireland.

Bullman S, Corcoran D, O'Leary J, O'Hare D, Lucey B, Sleator RD.

FEMS Immunol Med Microbiol. 2011 Nov;63(2):248-53. doi: 10.1111/j.1574-695X.2011.00847.x.

27.

Ins and outs of suprapubic catheters--a clinician's experience.

Bullman S.

Urol Nurs. 2011 Sep-Oct;31(5):259-63; quiz 264. Review.

PMID:
22073897
28.

Molecular-based detection of non-culturable and emerging campylobacteria in patients presenting with gastroenteritis.

Bullman S, O'Leary J, Corcoran D, Sleator RD, Lucey B.

Epidemiol Infect. 2012 Apr;140(4):684-8. doi: 10.1017/S0950268811000859. Epub 2011 May 18.

PMID:
21676357
29.

Campylobacter ureolyticus: an emerging gastrointestinal pathogen?

Bullman S, Corcoran D, O'Leary J, Lucey B, Byrne D, Sleator RD.

FEMS Immunol Med Microbiol. 2011 Mar;61(2):228-30. doi: 10.1111/j.1574-695X.2010.00760.x. Epub 2010 Dec 6.

30.

Imidacloprid induces neurobehavioral deficits and increases expression of glial fibrillary acidic protein in the motor cortex and hippocampus in offspring rats following in utero exposure.

Abou-Donia MB, Goldstein LB, Bullman S, Tu T, Khan WA, Dechkovskaia AM, Abdel-Rahman AA.

J Toxicol Environ Health A. 2008;71(2):119-30.

PMID:
18080902
31.

In utero exposure to nicotine and chlorpyrifos alone, and in combination produces persistent sensorimotor deficits and Purkinje neuron loss in the cerebellum of adult offspring rats.

Abou-Donia MB, Khan WA, Dechkovskaia AM, Goldstein LB, Bullman SL, Abdel-Rahman A.

Arch Toxicol. 2006 Sep;80(9):620-31. Epub 2006 Feb 16.

PMID:
16482470
32.

Systems of care for treatment of adolescent substance use disorders: background, principles and opportunities.

Nissen LB, Hunt SR, Bullman S, Marmo J, Smith D.

J Psychoactive Drugs. 2004 Dec;36(4):429-38. Review.

PMID:
15751481
33.

Co-exposure to pyridostigmine bromide, DEET, and/or permethrin causes sensorimotor deficit and alterations in brain acetylcholinesterase activity.

Abou-Donia MB, Dechkovskaia AM, Goldstein LB, Abdel-Rahman A, Bullman SL, Khan WA.

Pharmacol Biochem Behav. 2004 Feb;77(2):253-62.

PMID:
14751452
34.

Neurological deficits induced by malathion, DEET, and permethrin, alone or in combination in adult rats.

Abdel-Rahman A, Dechkovskaia AM, Goldstein LB, Bullman SH, Khan W, El-Masry EM, Abou-Donia MB.

J Toxicol Environ Health A. 2004 Feb 27;67(4):331-56. Review.

PMID:
14713564
35.

Sensorimotor deficits and increased brain nicotinic acetylcholine receptors following exposure to chlorpyrifos and/or nicotine in rats.

Abou-Donia MB, Abdel-Rahman A, Goldstein LB, Dechkovskaia AM, Shah DU, Bullman SL, Khan WA.

Arch Toxicol. 2003 Aug;77(8):452-8. Epub 2003 Apr 26.

PMID:
12937891
36.

Age but not sex affects motor recovery after unilateral sensorimotor cortex suction-ablation in the rat.

Goldstein LB, Bullman S.

Restor Neurol Neurosci. 1999;15(1):39-43.

PMID:
12671242
37.

Differential effects of haloperidol and clozapine on motor recovery after sensorimotor cortex injury in rats.

Goldstein LB, Bullman S.

Neurorehabil Neural Repair. 2002 Dec;16(4):321-5.

PMID:
12462763
38.

Uranyl acetate-induced sensorimotor deficit and increased nitric oxide generation in the central nervous system in rats.

Abou-Donia MB, Dechkovskaia AM, Goldstein LB, Shah DU, Bullman SL, Khan WA.

Pharmacol Biochem Behav. 2002 Jul;72(4):881-90.

PMID:
12062578
39.

Sensorimotor deficit and cholinergic changes following coexposure with pyridostigmine bromide and sarin in rats.

Abou-Donia MB, Dechkovskaia AM, Goldstein LB, Bullman SL, Khan WA.

Toxicol Sci. 2002 Mar;66(1):148-58.

PMID:
11861982
40.

Factors affecting client response to HIV outreach efforts.

Tinsman PD, Bullman S, Chen X, Burgdorf K, Herrell JM.

J Subst Abuse. 2001;13(1-2):201-14.

PMID:
11547620
41.

Effects of daily dermal application of DEET and epermethrin, alone and in combination, on sensorimotor performance, blood-brain barrier, and blood-testis barrier in rats.

Abou-Donia MB, Goldstein LB, Dechovskaia A, Bullman S, Jones KH, Herrick EA, Abdel-Rahman AA, Khan WA.

J Toxicol Environ Health A. 2001 Apr 6;62(7):523-41.

PMID:
11289702
42.

Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combination.

Abou-Donia MB, Goldstein LB, Jones KH, Abdel-Rahman AA, Damodaran TV, Dechkovskaia AM, Bullman SL, Amir BE, Khan WA.

Toxicol Sci. 2001 Apr;60(2):305-14.

PMID:
11248143
43.

Expression of the apolipoprotein E gene does not affect motor recovery after sensorimotor cortex injury in the mouse.

Goldstein LB, Vitek MP, Dawson H, Bullman S.

Neuroscience. 2000;99(4):705-10.

PMID:
10974433
44.

HIV outreach for hard-to-reach populations: a cross-site perspective.

Rowden DW, Dorsey PE, Bullman S, Lestina RP, Han C, Herrell JM.

Eval Program Plann. 1999 Aug;22(3):251-8.

PMID:
24011445
45.

Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients.

Brefel C, Thalamas C, Rayet S, Lopez-Gil A, Fitzpatrick K, Bullman S, Citerone DR, Taylor AC, Montastruc JL, Rascol O.

Br J Clin Pharmacol. 1998 Apr;45(4):412-5.

46.

Effects of dorsal noradrenergic bundle lesions on recovery after sensorimotor cortex injury.

Goldstein LB, Bullman S.

Pharmacol Biochem Behav. 1997 Dec;58(4):1151-7.

PMID:
9408227

Supplemental Content

Loading ...
Support Center